Increased Incidence of Necrotizing Enterocolitis in the Netherlands After Implementation of the New Dutch Guideline for Active Treatment in Extremely Preterm Infants: Results from Three Academic Referral Centers
Overview
Pediatrics
Authors
Affiliations
Introduction: Necrotizing enterocolitis (NEC) is a severe inflammatory disease, mostly occurring in preterm infants. The Dutch guidelines for active treatment of extremely preterm infants changed in 2006 from 26+0 to 25+0weeks of gestation, and in 2010 to 24+0 of gestation. We aimed to gain insight into the incidence, clinical outcomes and treatment strategies, in three academic referral centers in the Netherlands over the last nine years.
Methods: We performed a multicenter retrospective cohort study of all patients with NEC (Bell stage ≥2a) in three academic referral centers diagnosed between 2005 and 2013. Outcome measures consisted of incidence, changes in clinical presentation, treatment strategies and mortality.
Results: Between 2005 and 2013 14,161 children were admitted to the neonatal intensive care unit in the three centers. The overall percentage of children born at a gestational age of 24weeks and 25weeks increased with 1.7% after the introduction of the guidelines in 2006 and 2010. The incidence of NEC increased significantly (period 2005-2007: 2.1%; period 2008-2010 3.9%; period 2011-2013: 3.4%; P=0.001). We observed a significant decrease of peritoneal drainages (↓16%; P=0.001) and a decrease of laparotomies (↓24%; P=0.002). The mortality rate (33% in 2011-2013) remained unchanged.
Conclusion: The incidence of NEC significantly increased in the last nine years. The increase in incidence of NEC seemed to be related to an increase in infants born at a gestational age of 24 and 25weeks. The percentage of patients needing surgery decreased, while 30-day mortality did not change.
Level Of Evidence: Level IV.
Verhoeven R, Kupers T, Brunsch C, Hulscher J, Kooi E Children (Basel). 2025; 11(12.
PMID: 39767881 PMC: 11674918. DOI: 10.3390/children11121452.
Sarafidis K, Agakidou E, Kontou A, Agakidis C, Neu J Metabolites. 2024; 14(10).
PMID: 39452903 PMC: 11509608. DOI: 10.3390/metabo14100521.
Zhou J, Zhang Y, Zhang Z Front Pediatr. 2023; 11:1258846.
PMID: 38078326 PMC: 10704242. DOI: 10.3389/fped.2023.1258846.
Challis P, Kallen K, Bjorklund L, Elfvin A, Farooqi A, Hakansson S Arch Dis Child Fetal Neonatal Ed. 2023; 109(1):87-93.
PMID: 37788898 PMC: 10804036. DOI: 10.1136/archdischild-2023-325784.
van Varsseveld O, Ten Broeke A, Chorus C, Heyning N, Kooi E, Hulscher J Front Pediatr. 2023; 11:1122188.
PMID: 36925670 PMC: 10011167. DOI: 10.3389/fped.2023.1122188.